Alan Lovell's guest appearances

Alan Lovell

Assistive Technology Update with Josh Anderson

Gary Jackson Interview Archive

Open4Business from NLive Radio

Voces por la Salud / Voices for Health, by Roche 

Phil Jones

David Young

Keith Evans

David Clark

Brian Jones

Steve Hackett

Les McKeown

John Brennan

Mary Miller

David Logan

Peter Donegan

Ben Cohen

Jeff Brown

Sarah Martin

Peter Jones

OwlTail

Guest editor, Ivna Reic talks to Anna Borley-Russell and Alan Lovell, Senior Lecturers and Programme Leaders for Tourism programmes at the University of Northampton, about how they incorporate Sustainable Development Goals into the programme curricula. Originally broadcast 15th Feb 2022 on Open4Business on NLive Radio

Guest editor, Ivna Reic talks to Anna Borley-Russell and Alan Lovell, Senior Lecturers and Programme Leaders for Tourism programmes at the University of Northampton, about how they incorporate Sustainable Development Goals into the programme curricula. Originally broadcast 15th Feb 2022 on Open4Business on NLive Radio

Anna Borley-Russell and Alan Lovell - SDGs in the UoN Tourism Curricula 

In this episode of Voices for Health, a podcast by Roche, we focus on Personalized Healthcare or Precision Medicine. Personal health care is not a single intervention, it is a paradigm shift. Alan Lovell, from The Economist Intelligence Unit, says: "it's not possible to say that yet every intervention under the personalized medicine umbrella will prove worthy to adopt.  You know, that's true of any area of medical innovation.  But, having said that, the evidence does suggest that many personalized treatments, when spread across the Health System, are not only cost effective, but can actually lead to substantial savings and improve patient outcome. A study conducted in France found that investing just one point seven million euros in genetic testing for lung cancer patients could cut treatment costs by nearly seventy million euros". 

In this episode of Voices for Health, a podcast by Roche, we focus on Personalized Healthcare or Precision Medicine. Personal health care is not a single intervention, it is a paradigm shift. Alan Lovell, from The Economist Intelligence Unit, says: "it's not possible to say that yet every intervention under the personalized medicine umbrella will prove worthy to adopt.  You know, that's true of any area of medical innovation.  But, having said that, the evidence does suggest that many personalized treatments, when spread across the Health System, are not only cost effective, but can actually lead to substantial savings and improve patient outcome. A study conducted in France found that investing just one point seven million euros in genetic testing for lung cancer patients could cut treatment costs by nearly seventy million euros".

 Interview with Alan Lovell: "Universalizing the promise of innovation"- Voices for Health, a podcast by Roche   

Alan Lovell 9 July 2018

Alan Lovell - Swinging Blue Jeans 23 Sept 2016